Blood laboratory analyses preceding in-hospital cardiac arrest: A matched case-control study

Peter C Lind1,2, Nikola Stankovic1,2,3, Mathias J Holmberg1,2

  • 1Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Insights

Patients experiencing in-hospital cardiac arrest (IHCA) had more frequent blood tests before the event. Higher lactate levels were observed in IHCA patients compared to matched controls.

Area of Science:

  • Clinical Medicine
  • Biochemistry
  • Critical Care Medicine

Background:

  • Investigating differences in blood laboratory analyses between patients who experience in-hospital cardiac arrest (IHCA) and other hospitalized patients.
  • Understanding pre-arrest physiological markers is crucial for predicting and potentially preventing IHCA.

Purpose of the Study:

  • To compare the frequency, results, and trends of blood laboratory analyses in patients with IHCA versus matched controls.
  • To identify specific laboratory markers that may indicate an increased risk of IHCA.

Main Methods:

  • Matched case-control study utilizing Danish national registries from 2017 to 2021.
  • Included 9268 IHCA cases and 92,395 matched controls, comparing 51 blood laboratory analyses.
  • Focused on lactate, sodium, potassium, and hemoglobin, analyzing samples within 24 hours prior to the index time.

Main Results:

  • IHCA cases showed significantly higher sampling frequencies for all tested analytes compared to controls.
  • Lactate levels were notably higher in IHCA cases (median [IQR]: 2.3 [1.3, 4.9]) versus controls (median [IQR]: 1.3 [0.9, 2.0]).
  • Elevated lactate and potassium levels increased as the time to cardiac arrest decreased in cases, but not controls.

Conclusions:

  • Patients with IHCA undergo more frequent blood sampling before the event.
  • Higher pre-arrest lactate levels are a key differentiator in patients who experience IHCA.
  • Findings highlight the potential utility of monitoring lactate trends for IHCA risk assessment.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
138
Blood Studies I: ABG and VBG01:26

Blood Studies I: ABG and VBG

Blood studies are critical in the medical field, enabling healthcare professionals to assess a patient's health status accurately. This page will focus on two significant blood studies: Arterial Blood Gas (ABG) and Venous Blood Gas (VBG).
Arterial Blood Gas (ABG)
Arterial Blood Gas (ABG) studies are crucial for assessing the lungs' ability to supply oxygen and remove carbon dioxide, reflecting the patient's ventilation status. They also help understand the kidneys' capacity to...
492
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
77